Back
Candel Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64
CADL
Candel Therapeutics
Last Price:
$6.74
Seasonality Move:
-18.58%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CADL is experiencing slight selling pressure.
Candel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.22 | Buy |
| 20-day SMA: | 5.44 | Buy |
| 50-day SMA: | 5.41 | Buy |
| 200-day SMA: | 6.36 | Buy |
| 8-day EMA: | 6.26 | Buy |
| 20-day EMA: | 5.77 | Buy |
| 50-day EMA: | 5.61 | Buy |
| 200-day EMA: | 6 | Buy |
Candel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 69.53 | Buy |
| Chaikin Money Flow: | -636939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.73 - 6.05) | Buy |
| Bollinger Bands (100): | (4.57 - 7.45) | Buy |
Candel Therapeutics Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Candel Therapeutics Stock
Is Candel Therapeutics Stock a Buy?
-
Candel Therapeutics share price is 6.92 while CADL 8-day simple moving average is 6.22, which is a Buy signal.
-
The stock price of CADL is 6.92 while Candel Therapeutics 20-day SMA is 5.44, which makes it a Buy.
-
Candel Therapeutics 50-day simple moving average is 5.41 while CADL share price is 6.92, making it a Buy technically.
-
CADL stock price is 6.92 and Candel Therapeutics 200-day simple moving average is 6.36, creating a Buy signal.
CADL Technical Analysis vs Fundamental Analysis
Buy
64
Candel Therapeutics (CADL)
is a Buy
Is Candel Therapeutics a Buy or a Sell?
-
Candel Therapeutics stock is rated a BuyThe current Candel Therapeutics [CADL] share price is $6.92. The Score for CADL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Candel Therapeutics Stock Info
Market Cap:
346.7M
Price in USD:
6.92
Share Volume:
1.3M
Candel Therapeutics 52-Week Range
52-Week High:
14.60
52-Week Low:
3.79
Buy
64
Candel Therapeutics (CADL)
is a Buy
Candel Therapeutics Share Price Forecast
-
What is the Candel Therapeutics stock price today?The Candel Therapeutics stock price is 6.92 USD today.
-
Will CADL stock go up or go down?Candel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Candel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Candel Therapeutics is not overvalued.
Is Candel Therapeutics Stock a Buy?
-
Candel Therapeutics share price is 6.92 while CADL 8-day exponential moving average is 6.26, which is a Buy signal.
-
The stock price of CADL is 6.92 while Candel Therapeutics 20-day EMA is 5.77, which makes it a Buy.
-
Candel Therapeutics 50-day exponential moving average is 5.61 while CADL share price is 6.92, making it a Buy technically.
-
CADL stock price is 6.92 and Candel Therapeutics 200-day simple moving average is 6.00, creating a Buy signal.
Fundamental Analysis of Candel Therapeutics
Is Candel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.03 per share.
Technical Analysis of Candel Therapeutics
Should I short Candel Therapeutics stock?
-
CADL Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting Candel Therapeutics is a Buy
-
Candel Therapeutics Relative Strength Index (RSI) is 69.53, which suggest Candel Therapeutics is overbought
-
The Bollinger Bands (25) for Candel Therapeutics is (4.73 - 6.05), which suggest Candel Therapeutics is a Buy
-
The Bollinger Bands (100) for Candel Therapeutics is (4.57 - 7.45), which suggest Candel Therapeutics is a Buy
* Candel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.